BVMF/ABTT34 (BVMF/ABTT34)

Brazil Stock Exchange: BVMF/ABTT34 · BRL

R$46.1

-1.04 (-2.2%)· Recorded snapshot

Market cap	953.9B
Revenue (ttm)	249.8B
Net income (ttm)	24.2B
EPS (ttm)	R$1.20
P/E (trailing)	38.4x
P/E (forward)	17.5x
Dividend	R$0.72 (1.57%)
Volume	87
Beta	0.58

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 249.8B
Net income (ttm): 24.2B
EPS (ttm): R$1.20
P/E (trailing): 38.4x
P/E (forward): 17.5x
Market cap: 953.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E17.5

P25 n/aP50 n/aP75 n/a

Trailing P/E38.4

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/ABTT34 indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-21
Employees	122,000
Employees change	7,000
Employees growth	6.09%
Enterprise value	BRL 1.1T
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1888
Industry	Medical Devices
Is primary listing	No
ISIN number	BRABTTBDR007
Last earnings date	2026-10-21
Last refreshed	2026-10-28
Last stock split date	2022-11-21
Last stock split type	Forward
Market cap	BRL 953.9B
Price	BRL 46.10
Price currency	BRL
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-27
Symbol	bvmf/ABTT34
Website	https://www.abbott.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	50.21x
Average P/E ratio (3Y)	27.41x
Average P/E ratio (5Y)	28.1x
Earnings yield	2.6%
EV/Earnings	45.5x
EV/EBIT	25.83x
EV/EBITDA	16.7x
EV/FCF	26.32x
EV/Sales	4.27x
FCF / EV yield	3.8%
FCF yield	4.39%
Forward P/E	17.55x
Graham number	18.4753
Graham upside	-59.92%
Lynch fair value	BRL 5.85
Lynch upside	-87.3%
P/(FCF - SBC) ratio	25.08x
P/(OCF - SBC) ratio	19.4x
P/B ratio	3.56x
P/E ratio	38.41x
P/FCF ratio	22.78x
P/OCF ratio	17.99x
P/S ratio	3.82x
Price/EBITDA ratio	15.41x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.55%
EBITDA margin	24.79%
Effective tax rate	28.36%
FCF margin	16.8%
Gross margin	57.08%
Operating margin	16.55%
Pretax margin	13.61%
Profit margin	9.75%
Profit per employee	BRL 210,664
Profitable quarters	34
Profitable years	35
Revenue per employee	BRL 2.2M
ROA	5.33%
ROA (5Y)	6.84%
ROCE	9.01%
ROE	10.58%
ROE (5Y)	19.7%
ROIC	7.25%
ROIC (5Y)	14.92%
SBC / revenue	1.54%
Tax / revenue	3.86%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-66.24%
EPS growth (Q)	-43.69%
EPS growth (QoQ)	-0.12%
EPS growth 10Y	11.38%
EPS growth 3Y	-2.87%
EPS growth 5Y	-7.76%
EPS growth years	0
FCF growth	15.48%
FCF growth 3Y	12.55%
FCF growth 5Y	-1.97%
Gross profit growth	12.07%
Gross profit growth (Q)	17.95%
Gross profit growth 3Y	7.75%
Gross profit growth 5Y	2.62%
Net income growth	-66.37%
Net income growth (Q)	-44.04%
Net income growth (QoQ)	-0.86%
Net income growth 3Y	-3.11%
Net income growth 5Y	-8.3%
Net income growth years	0
OCF growth	9.61%
OCF growth 10Y	13.31%
OCF growth 3Y	9.95%
OCF growth 5Y	-1.4%
Operating income growth	-5.19%
Operating income growth (Q)	-33.06%
Operating income growth 3Y	5.37%
Operating income growth 5Y	-2.23%
Revenue growth	10%
Revenue growth (Q)	14.46%
Revenue growth (QoQ)	3.34%
Revenue growth 10Y	8.82%
Revenue growth 3Y	6.47%
Revenue growth 5Y	2.65%
Revenue growth quarters	11
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -11.1B
Depreciation and amortization	BRL 21.3B
EBIT	BRL 41.3B
EBITDA	BRL 61.9B
EPS	BRL 1.20
Financing cash flow	BRL 56.9B
Free cash flow	BRL 41.9B
Free cash flow minus SBC	BRL 38B
Gross profit	BRL 142.6B
Income taxes	BRL 9.6B
Investing cash flow	BRL -119.7B
Net borrowing	BRL 88.5B
Net cash flow	BRL -9.9B
Net income	BRL 24.2B
Operating cash flow minus SBC	BRL 49.2B
Operating income	BRL 41.3B
Revenue	BRL 249.8B
Stock-based compensation	BRL 3.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	BRL 153.00
Debt / EBITDA	2.65
Debt / equity	0.63
Debt / FCF	4.05
Interest coverage	7.87
Net cash (debt)	BRL -140.5B
Net cash / market cap	-14.72%
Net debt / EBITDA	2.27
Net debt / equity	0.52
Net debt / FCF	3.35
Piotroski F-Score	5
Shareholders' equity	BRL 268.1B
Tangible book value	BRL -7B
Tangible book value per share	BRL -4.03
Total cash	BRL 29B
Total debt	BRL 169.5B
WACC	6.67%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current ratio	1.38
Inventory turnover	2.82
Quick ratio	0.8
Working capital	BRL 35.9B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.25%
Dividend growth	11.28%
Dividend growth (10Y)	5.07%
Dividend growth (3Y)	7.26%
Dividend growth (5Y)	7.07%
Dividend growth years	6
Dividend payment date	2026-11-23
Dividend payment years	15
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.72
Dividend yield	1.57%
Ex-dividend date	2026-10-14
Last dividend	BRL 0.04
Payout ratio	60.32%
Shareholder yield	1.81%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	343.14%
10Y return CAGR	17.68%
10Y total return	409.03%
150-day SMA	BRL 42.04
1D price change	-2.21%
1M price change	5.01%
1M total return	5.46%
1W price change	5.64%
1W total return	5.64%
1Y price change	-18.8%
1Y return CAGR	-17.45%
1Y total return	-17.44%
20-day SMA	BRL 43.04
200-day SMA	BRL 44.07
3M price change	5.56%
3M total return	6.01%
3Y price change	17.69%
3Y return CAGR	7.08%
3Y total return	22.79%
50-day SMA	BRL 45.21
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 58.85
52-week high date	2025-12-30
52-week low	BRL 33.50
52-week low date	2026-05-11
5Y price change	-22.93%
5Y return CAGR	-3.8%
5Y total return	-17.62%
6M price change	20.71%
6M total return	21.8%
All-time high	BRL 67.65
All-time high date	2025-02-28
All-time low	BRL 5.57
All-time low date	2013-01-28
Average true range (ATR)	BRL 1.61
Average volume	570
Beta (5Y)	0.58
Change from 52-week high	-21.67%
Change from 52-week low	37.61%
Change from all-time high	-31.86%
Change from all-time low	728.09%
Change from open	-1.07%
Day's gap	-1.15%
Dollar volume	BRL 4,011
High price	BRL 46.60
Low price	BRL 45.85
Monthly RSI	46.51
Open price	BRL 46.60
Position in 52-week range	33.33%
Previous close	BRL 47.14
Price vs 150-day SMA	9.67%
Price vs 20-day SMA	7.11%
Price vs 200-day SMA	4.61%
Price vs 50-day SMA	1.98%
Relative volume	0.15
RSI	57.59
Sharpe ratio	-0.47
Sharpe ratio (3Y)	0.11
Sharpe ratio (5Y)	-0.03
Sortino ratio	-0.56
Sortino ratio (3Y)	0.34
Sortino ratio (5Y)	0.14
Volume	87
Weekly RSI	53.61
YTD price change	-19.63%
YTD total return	-18.29%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7B
Shares change (QoQ)	-0.29%
Shares change (YoY)	-0.25%
Shares held by insiders	0.5%
Shares held by institutions	80.98%
Short ratio	1.9 days

Deeper analysis on BVMF/ABTT34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/ABTT34 report

Is a complete BVMF/ABTT34 research report available?

No complete published report is available for bvmf/ABTT34 (BVMF/ABTT34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/ABTT34 (BVMF/ABTT34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/ABTT34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/ABTT34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/ABTT34

Frequently asked questions